SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-18-000366
Filing Date
2018-02-01
Accepted
2018-02-01 18:00:35
Documents
1
Period of Report
2018-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form410959006_02012018.html 4  
1 OWNERSHIP DOCUMENT form410959006_02012018.xml 4 7558
  Complete submission text file 0000921895-18-000366.txt   9572
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 122 E.42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address
Lipman Matthew E. (Reporting) CIK: 0001687758 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21214 | Film No.: 18567976

Mailing Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168 212-302-0699
BP Peptides, LLC (Reporting) CIK: 0001711689 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-21214 | Film No.: 18567975